Iteos TherapeuticsITOS
13F holders, Q3 2025 (September 30)1holders −136
0new positions
135sold out
$10.15avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Iteos Therapeutics Inc. (ITOS) in their 13F filings, down 136 from Q2 2025. 0 opened new positions and 135 sold out. The largest holder was IFP Advisors, Inc ($2K).
- Company
- Iteos Therapeutics Inc.
- CUSIP
- 46565G104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 135 | $376.7M |
All 13F filers, Q2 2025 → Q3 2025: 2 shares bought and 37,785,372 shares sold, net −37,785,370 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | Add +0.9% | 232 | $2K |
"% of holder's portfolio" is ITOS's weight in each manager's 13F, not the share of Iteos Therapeutics Inc. the manager owns.